Founded in 2016, Strong-Link Med (Beijing) Technology Co., Ltd. is a pioneer and leader in AI diagnosis and treatment for neurovascular diseases in China, focused on building full-stack AI medical solutions. The company has long collaborated with multiple national neuro-disease medical centers for collaborative innovation, with strong technical strength: nearly 150 authorized patents, nearly 50 software copyrights, and multiple research achievements. It is recognized as a national key "Little Giant" specialist company and a national intellectual property advantage enterprise. Centered on "DEEP AI for NEURO," the company has built a product-service system covering the full process of diagnosis, assessment, surgery, and patient management, across full scenarios of clinical treatment, physician training, medical research, and patient education. The company will continue to leverage its self-developed core product, the UMate™ series AI catheter-shaping robots, to build a world-leading intelligent diagnosis and treatment service platform for neurovascular diseases.